Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App

Via Peters

First Smartphone App FDA cleared for Insulin Delivery on Both iOS and Android Operating Systems SAN DIEGO–(BUSINESS WIRE)– Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of bolus insulin dosing on the t:slim X2 insulin pump […]